{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:29:36Z","timestamp":1775183376359,"version":"3.50.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To study the association between thrombocytopenia and retinopathy of prematurity (ROP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The case-control study was conducted on preterm newborns with ROP between January 2011 and January 2014, retrospectively. The patients were assigned into two groups: Cases required intervention and controls developed no or Stage I ROP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Eighty-one premature infants with Type I ROP were enrolled to the study with a mean gestational age of 27.6 \u00b1 2.1 (range: 24\u201332) weeks and birth weight of 993 \u00b1 292 (range: 560\u20131,930) g. Mean follow-up time was 38.3 \u00b1 2.7 weeks (min: 32 and max: 46 weeks). Cases were individually matched to a set of controls (1:1 ratio). Thrombocytopenia (&lt;150.000\/mm<jats:sup>3<\/jats:sup>) was seen in 58 (71.6%) of the cases with Type I ROP, whereas only 17 (21%) of the controls had thrombocytopenia (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Logistic regression analysis showed that bronchopulmonary dysplasia and thrombocytopenia were significantly associated with Type I ROP (relative risk [95% confidence interval]: 4.19 [1.47\u201312] and 6.69 [2.83\u201315.9], respectively). The thrombocytopenia ratio (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.073), thrombocytopenia 1 week before intervention (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.076) and platelet transfusion ratio (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.062) tended to be higher in Zone I ROP compared with Zone II ROP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In our study, there was a significant association between thrombocytopenia and Type I ROP.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000002028","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T16:38:22Z","timestamp":1516811902000},"page":"706-711","source":"Crossref","is-referenced-by-count":17,"title":["THROMBOCYTOPENIA AS A RISK FACTOR FOR RETINOPATHY OF PREMATURITY"],"prefix":"10.1097","volume":"39","author":[{"given":"Selim","family":"Sancak","sequence":"first","affiliation":[{"name":"Neonatal Intensive Care Unit, Zeynep Kamil Maternity and Children's Training and Research Hospital, Istanbul, TR; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handan H.","family":"Toptan","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Zeynep Kamil Maternity and Children's Training and Research Hospital, Istanbul, TR; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulin","family":"Gokmen Yildirim","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Zeynep Kamil Maternity and Children's Training and Research Hospital, Istanbul, TR; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guner","family":"Karatekin","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Zeynep Kamil Maternity and Children's Training and Research Hospital, Istanbul, TR; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahri","family":"Ovali","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Medeniyet University, Istanbul, TR."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1620\/tjem.230.185","article-title":"Low incidence of sight-threatening retinopathy of prematurity in infants born before 28 weeks gestation at a neonatal intensive care unit in Japan","volume":"230","author":"Aikawa","year":"2013","journal-title":"Tohoku J Exp Med"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaapos.2012.09.004","article-title":"An update on progress and the changing epidemiology of causes of childhood blindness worldwide","volume":"16","author":"Kong","year":"2012","journal-title":"J AAPOS"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ajo.2004.12.106","article-title":"Involution of retinopathy of prematurity after laser treatment: factors associated with development of retinal detachment","volume":"140","author":"Coats","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clp.2013.02.001","article-title":"Retinopathy of prematurity-incidence today","volume":"40","author":"Zin","year":"2013","journal-title":"Clin Perinatol"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bjophthalmol-2014-306286","article-title":"Incidence and severity of retinopathy of prematurity in Turkey","volume":"99","author":"Bas","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/2249-4847.96755","article-title":"Retinopathy of prematurity: a study of incidence and risk factors in NICU of Al-Minya University Hospital in Egypt","volume":"1","author":"Abdel","year":"2012","journal-title":"J Clin Neonatol"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"5918736","DOI":"10.1155\/2016\/5918736","article-title":"A prospective study of the incidence of retinopathy of prematurity in China: evaluation of different screening criteria","volume":"2016","author":"Li","year":"2016","journal-title":"J Ophthalmol"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1590\/S1020-49892009000900005","article-title":"Prevalence of retinopathy of prematurity: an institutional cross-sectional study of preterm infants in Brazil","volume":"26","author":"Fortes Filho","year":"2009","journal-title":"Rev Panam Salud Publica"},{"key":"R9-20230816","article-title":"Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006-2015: a population-based analysis","author":"Gerull","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"R10-20230816","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/oxfordjournals.bmb.a070758","article-title":"Retinal angiogenesis in the human embryo","volume":"26","author":"Ashton","year":"1970","journal-title":"Br Med Bull"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0002-9394(77)90377-4","article-title":"Retinal vascular development in premature infants","volume":"84","author":"Roth","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R13-20230816","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaapos.2012.12.155","article-title":"Effects of oxygen on the development and severity of retinopathy of prematurity","volume":"17","author":"Hartnett","year":"2013","journal-title":"J AAPOS"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat Med"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/bjo.2007.128371","article-title":"VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity","volume":"92","author":"Pieh","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R18-20230816","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R19-20230816","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2013.01.006","article-title":"Nutrition, insulin-like growth factor-1 and retinopathy of prematurity","author":"Hard","year":"2013","journal-title":"Semin Fetal Neonatal Med."},{"key":"R20-20230816","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","article-title":"Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity","volume":"98","author":"Hellstrom","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/pr.2012.146","article-title":"Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety","volume":"73","author":"Ley","year":"2013","journal-title":"Pediatr Res"},{"key":"R22-20230816","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMoa041773","article-title":"Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy","volume":"353","author":"Watanabe","year":"2005","journal-title":"N Engl J Med"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clp.2013.02.002","article-title":"The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment","volume":"40","author":"Smith","year":"2013","journal-title":"Clin Perinatol"},{"key":"R24-20230816","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1542\/peds.2005-2749","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"117","year":"2006","journal-title":"Pediatrics"},{"key":"R25-20230816","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1074\/jbc.275.3.1521","article-title":"The hemostatic system as a regulator of angiogenesis","volume":"275","author":"Browder","year":"2000","journal-title":"J Biol Chem"},{"key":"R26-20230816","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.94.2.663","article-title":"Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets","volume":"94","author":"Mohle","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-20230816","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1688470","article-title":"Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides","volume":"247","author":"Maione","year":"1990","journal-title":"Science"},{"key":"R28-20230816","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","article-title":"Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released","volume":"111","author":"Italiano","year":"2008","journal-title":"Blood"},{"key":"R29-20230816","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R30-20230816","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3928\/01913913-20080501-12","article-title":"An epidemiologic analysis of retinopathy of prematurity over 10 years","volume":"45","author":"Giannantonio","year":"2008","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R31-20230816","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1084-2756(03)00119-2","article-title":"Pathogenesis of retinopathy of prematurity","volume":"8","author":"Smith","year":"2003","journal-title":"Semin Neonatol"},{"key":"R32-20230816","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1537-2995.2008.02074.x","article-title":"Very high users of platelet transfusions in the neonatal intensive care unit","volume":"49","author":"Dohner","year":"2009","journal-title":"Transfusion"},{"key":"R33-20230816","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"R34-20230816","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1073\/pnas.0510412103","article-title":"Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage","volume":"103","author":"Kisucka","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R35-20230816","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09537100120068170","article-title":"The platelet release reaction: granules'constituents, secretion and functions","volume":"12","author":"Rendu","year":"2001","journal-title":"Platelets"},{"key":"R36-20230816","doi-asserted-by":"crossref","first-page":"8609","DOI":"10.1016\/S0021-9258(17)34336-3","article-title":"Isolation and characterization of a high molecular weight glycoprotein from human blood platelets","volume":"253","author":"Lawler","year":"1978","journal-title":"J Biol Chem"},{"key":"R37-20230816","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1182\/blood-2009-09-242065","article-title":"Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis","volume":"115","author":"Zaslavsky","year":"2010","journal-title":"Blood"},{"key":"R38-20230816","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2008-06-159541","article-title":"Platelets actively sequester angiogenesis regulators","volume":"113","author":"Klement","year":"2009","journal-title":"Blood"},{"key":"R39-20230816","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2007-04-084798","article-title":"Platelet-associated PF-4 as biomarker of early tumor growth","volume":"111","author":"Cervi","year":"2008","journal-title":"Blood"},{"key":"R40-20230816","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/IAE.0b013e3181cafc30","article-title":"Do platelets have a role in the pathogenesis of aggressive posterior retinopathy of prematurity?","volume":"30","author":"Vinekar","year":"2010","journal-title":"Retina"},{"key":"R41-20230816","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.jaapos.2011.01.015","article-title":"Thrombocytopenia and retinopathy of prematurity","volume":"15","author":"Jensen","year":"2011","journal-title":"J AAPOS"},{"key":"R42-20230816","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.eye.6700296","article-title":"Retinopathy of prematurity in practice. I: screening for threshold disease","volume":"17","author":"Brennan","year":"2003","journal-title":"Eye (Lond)"},{"key":"R43-20230816","first-page":"4117","article-title":"Effect of thrombocytopenia on the progression of threshold retinopathy of prematurity (ROP) after laser photocoagulation","volume":"46","author":"Kuppermann","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R44-20230816","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/MPH.0b013e31821e5f44","article-title":"Drop in platelet counts in extremely preterm neonates and its association with clinical outcomes","volume":"33","author":"Rastogi","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"R45-20230816","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/IAE.0b013e31815075b0","article-title":"Association of systemic risk factors with the progression of laser-treated retinopathy of prematurity to retinal detachment","volume":"28","author":"Bourla","year":"2008","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006982-201904000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:12:40Z","timestamp":1692231160000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201904000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000002028","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}